跳至主要内容
临床试验/IRCT20170216032603N2
IRCT20170216032603N2招募中2 期

Comparison between the efficacy and side effects of Levetiracetam versus Carbamazepine as mono therapy in treatment of partial epilepsy of the children between 2 to 14 years old

Alborz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 14 years(—)
性别
All

入选标准

  • 2-14 years old
  • Partial epilepsy as a new onset
  • No history of renal disease
  • No history of liver disease
  • No history of cerebral palsy
  • Acceptance to be part of this study

排除标准

  • Epilepsy in patients with any brain damage from three month ago
  • History of taking any anti-epileptic medications
  • History of liver disease
  • History of renal disease
  • History of neurological disease under medical treatment

研究者

发起方
Alborz University of Medical Sciences

相似试验